Inhibition of autophagy by YC-1 promotes gefitinib induced apoptosis by targeting FOXO1 in gefitinib-resistant NSCLC cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of autophagy by YC-1 promotes gefitinib induced apoptosis by targeting FOXO1 in gefitinib-resistant NSCLC cells

Published:2021-10 Issue: Volume:908 Page:174346
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Hu Hui,Zhang Xiao-Wei,Li Lin,Hu Ming-Ning,Hu Wen-Qian,Zhang Jing-Ying,Miao Xiao-Kang,Yang Wen-Le,Mou Ling-Yun

Funder

National Natural Science Foundation of China

Ministry of Education of the People's Republic of China

Chinese Academy of Meteorological Sciences

Science and Technology Program of Gansu Province

Publisher

Elsevier BV

Subject

Pharmacology

Reference57 articles.

1. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma;Amaravadi;J. Clin. Invest.,2007

2. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions;Balsara;Carcinogenesis,2004

3. Role of FoxO proteins in cellular response to antitumor agents;Beretta;Cancers,2019

4. Autophagy in tumour suppression and promotion;Brech;Mol. Oncol.,2009

5. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor;Brunet;Cell,1999

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific Deletions of Chromosomes 3p, 5q, 13q, and 21q among Patients with G2 Grade of Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2024-08-08

2. PD-L1 induces autophagy and primary resistance to EGFR–TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway;Cell Death & Disease;2024-08-01

3. β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy;Pharmaceuticals;2024-05-14

4. Targeting IL-6/STAT3 signaling abrogates EGFR-TKI resistance through inhibiting Beclin-1 dependent autophagy in HNSCC;Cancer Letters;2024-04

5. Mechanistic Prediction and validation of Brevilin A Therapeutic Effects in Lung Cancer;2024-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3